← Back to Search

Emotional Support Plan for Autism Spectrum Disorder

N/A
Waitlist Available
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria Adults 18 years or older with previously established diagnoses in ASD will be invited to participate. Adults who have a verbal IQ above 70 or who are students admitted to a college or university will be included in the study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 week study period
Awards & highlights

Study Summary

This study is evaluating whether a brief telehealth intervention can help autistic adults cope with negative emotions during the COVID-19 pandemic.

Eligible Conditions
  • Autism Spectrum Disorder
  • Stress
  • Psychological Distress
  • Autism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 week study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 week study period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decreased anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)
Decreased distress on EMA reports
Decreased distress on Patient Health Questionnaire (PHQ-9)
Secondary outcome measures
Adult Self Report (ASR)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Emotional Support Plan (ESP) + Weekly MonitoringExperimental Treatment1 Intervention
This will involve weekly assessments without prompting to use the plan.
Group II: Emotional Support Plan (ESP) + 4x Daily MonitoringExperimental Treatment2 Interventions
Participants in this arm will be prompted on their phones 4x/day randomly, to report on activities, mood, suicidal ideation, distress level and ESP use since the last prompt
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Daily Monitoring
2020
N/A
~30
Emotional Support Plan
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,242 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
151 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19
Vanessa H. Bal, PhD 2020. "ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04460677.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top